Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Hydration Pharmaceuticals Co. Ltd. has reported a successful fiscal year 2023, with net sales up by 10% to $10M, gross profit increasing 15% to $5.4M, and a significant reduction in operating cash burn by 41%. The company also slashed Sales and Marketing expenses by $2.4M, optimizing marketing costs to 39% of sales, down from the previous year’s 74%.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.
